The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp Pfizer's Pivotal Leap: BMO Analyst Seigerman Declares Bullish Outlook on Long-Awaited Obesity Market Entry via Metsara Deal Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid